JP3520880B2 - Oxadiazole derivative and method for producing the same - Google Patents

Oxadiazole derivative and method for producing the same

Info

Publication number
JP3520880B2
JP3520880B2 JP14675695A JP14675695A JP3520880B2 JP 3520880 B2 JP3520880 B2 JP 3520880B2 JP 14675695 A JP14675695 A JP 14675695A JP 14675695 A JP14675695 A JP 14675695A JP 3520880 B2 JP3520880 B2 JP 3520880B2
Authority
JP
Japan
Prior art keywords
group
general formula
formula
chemical
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP14675695A
Other languages
Japanese (ja)
Other versions
JPH08311051A (en
Inventor
望 田元
一清 永井
千波矢 安達
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ricoh Co Ltd
Original Assignee
Ricoh Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ricoh Co Ltd filed Critical Ricoh Co Ltd
Priority to JP14675695A priority Critical patent/JP3520880B2/en
Publication of JPH08311051A publication Critical patent/JPH08311051A/en
Application granted granted Critical
Publication of JP3520880B2 publication Critical patent/JP3520880B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、有機EL素子用の材料
として有用な新規オキサジアゾール誘導体及びそれらの
製造方法に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to novel oxadiazole derivatives useful as materials for organic EL devices and methods for producing them.

【0002】[0002]

【従来の技術】有機EL素子を構成する発光成分あるい
は電子輸送成分として、種々のオキサジアゾール誘導体
が知られている。例えば、日本化学会誌、1991、N
o.11、p.1540から1548には、各種オキサ
ジアゾール誘導体が発光材料あるいは電子輸送材料とし
て有用であることが報告されている。しかし、素子の安
定性の他、発光輝度や発光効率については十分な値が得
らておらず、更なる高輝度化が望まれている。
2. Description of the Related Art Various oxadiazole derivatives are known as a light emitting component or an electron transporting component constituting an organic EL device. For example, The Chemical Society of Japan, 1991, N.
o. 11, p. 1540 to 1548 report that various oxadiazole derivatives are useful as a light emitting material or an electron transporting material. However, in addition to the stability of the device, sufficient values have not been obtained for light emission brightness and light emission efficiency, and further higher brightness is desired.

【0003】[0003]

【発明が解決しようとする課題】本発明は、高輝度及び
高発光効率を有する有機EL素子の構成成分として有用
な新規オキサジアゾール誘導体及びその製造方法を提供
することを目的とする。
SUMMARY OF THE INVENTION It is an object of the present invention to provide a novel oxadiazole derivative useful as a constituent component of an organic EL device having high brightness and high luminous efficiency and a method for producing the same.

【0004】[0004]

【課題を解決するための手段】本発明者らは、上記課題
を解決するため鋭意検討した結果、ある特定な構造を有
するオキサジアゾール誘導体が有機EL素子の構成成分
として有効であることを見いだし、本発明を完成するに
至った。即ち、本発明によれば、下記一般式(1)
Means for Solving the Problems As a result of intensive studies for solving the above problems, the present inventors have found that an oxadiazole derivative having a specific structure is effective as a constituent component of an organic EL device. The present invention has been completed. That is, according to the present invention, the following general formula (1)

【化1】 〔式中、Aは、置換もしくは無置換の芳香族炭化水素
基、置換もしくは無置換の芳香族複素環基を表し、それ
ぞれ同一でも異なっていても良い。R1、R2は、水素原
子、ハロゲン原子、置換もしくは無置換のアルキル基、
アルコキシ基、アリール基、アミノ基、シアノ基、ヒド
ロキシル基を表し、それぞれ同一でも異なっていても良
い。nは、2又は3の整数を表す(但し、3の場合は、
ベンゼン環の1、3、5位に結合する)。〕で表される
オキサジアゾール誘導体が提供され、また、本発明によ
れば、下記一般式(2)
[Chemical 1] [In the formula, A represents a substituted or unsubstituted aromatic hydrocarbon group or a substituted or unsubstituted aromatic heterocyclic group, which may be the same or different. R 1 and R 2 are a hydrogen atom, a halogen atom, a substituted or unsubstituted alkyl group,
It represents an alkoxy group, an aryl group, an amino group, a cyano group, and a hydroxyl group, which may be the same or different. n represents an integer of 2 or 3 (however, in the case of 3,
It is attached to the 1, 3 and 5 positions of the benzene ring). ] The oxadiazole derivative represented by the following is also provided, and according to the present invention, the following general formula (2)

【化2】 〔式中、R2は、水素原子、ハロゲン原子、置換もしく
は無置換のアルキル基、アルコキシ基、アリール基、ア
ミノ基、シアノ基、ヒドロキシル基を表す。Xは、ハロ
ゲン原子を表す。nは、2又は3の整数を表す(但し、
3の場合は、ベンゼン環の1、3、5位に結合す
る)。〕で表される酸ハライド化合物と、下記一般式
(3)
[Chemical 2] [In the formula, R 2 represents a hydrogen atom, a halogen atom, a substituted or unsubstituted alkyl group, an alkoxy group, an aryl group, an amino group, a cyano group, or a hydroxyl group. X represents a halogen atom. n represents an integer of 2 or 3 (however,
In the case of 3, it is bonded to the 1, 3 and 5 positions of the benzene ring). ] The acid halide compound represented by the following general formula (3)

【化3】 〔式中、Aは、置換もしくは無置換の芳香族炭化水素
基、置換もしくは無置換の芳香族複素環基を表し、それ
ぞれ同一でも異なっていても良い。R1は、水素原子、
ハロゲン原子、置換もしくは無置換のアルキル基、アル
コキシ基、アリール基、アミノ基、シアノ基、ヒドロキ
シル基を表す。〕で表されるテトラゾール化合物とを反
応させて、前記一般式(1)で表されるオキサジアゾー
ル誘導体を製造することを特徴とするオキサジアゾール
誘導体の製造方法が提供される。
[Chemical 3] [In the formula, A represents a substituted or unsubstituted aromatic hydrocarbon group or a substituted or unsubstituted aromatic heterocyclic group, which may be the same or different. R 1 is a hydrogen atom,
It represents a halogen atom, a substituted or unsubstituted alkyl group, an alkoxy group, an aryl group, an amino group, a cyano group, or a hydroxyl group. ] In with a tetrazole compound is reacted represented method oxadiazole derivatives, characterized by producing an oxadiazole derivative represented by the general formula (1) is Ru are provided.

【0005】本発明の、前記一般式(1)で表されるオ
キサジアゾール誘導体の具体的な構造は、下記一般式
(6)、(7)、(8)又は(9)で表される。
The specific structure of the oxadiazole derivative represented by the general formula (1) of the present invention is represented by the following general formula (6), (7), (8) or (9). .

【化6】 [Chemical 6]

【化7】 [Chemical 7]

【化8】 [Chemical 8]

【化9】 〔式(6)、(7)、(8)、(9)中、A、R1及び
2は前記と同じ。〕
[Chemical 9] [In the formulas (6), (7), (8) and (9), A, R 1 and R 2 are the same as above. ]

【0006】前記一般式(1)で表されるオキサジアゾ
ール誘導体において、Aに示される芳香族炭化水素基ま
たは芳香族複素環基の具体例としては、スチリル、フェ
ニル、ビフェニル、ターフェニル、ナフチル、アントリ
ル、アセナフテニル、フルオレニル、フェナントリル、
インデニル、ピレニル、ピリジル、ピリミジル、フラニ
ル、ピロニル、チオフェニル、キノリル、ベンゾフラニ
ル、ベンゾチオフェニル、インドリル、カルバゾリル、
ベンゾオキサゾリル、キノキサリル、ベンゾイミダゾリ
ル、ピラゾリル、ジベンゾフラニル、ジベンゾチオフェ
ニル、オキサゾリル、オキサジアゾリル基等が挙げられ
る。また、これら芳香族炭化水素基または芳香族複素環
基の置換基としては、ハロゲン原子、水酸基、シアノ
基、ニトロ基、アミノ基、トリフルオロメチル基、炭素
数1から6のアルキル基、アルコキシ基、アリールオキ
シ基、フェニル基、スチリル基、ナフチル基、チオフェ
ニル基、アラルキル基、ビフェニル基、ビチオフェニル
基、フラニル基、ビフラニル基、ピロニル基、ビピロニ
ル基等が挙げられる。
In the oxadiazole derivative represented by the general formula (1), specific examples of the aromatic hydrocarbon group or aromatic heterocyclic group represented by A include styryl, phenyl, biphenyl, terphenyl and naphthyl. , Anthryl, acenaphthenyl, fluorenyl, phenanthryl,
Indenyl, pyrenyl, pyridyl, pyrimidyl, furanyl, pyronyl, thiophenyl, quinolyl, benzofuranyl, benzothiophenyl, indolyl, carbazolyl,
Examples thereof include benzoxazolyl, quinoxalyl, benzimidazolyl, pyrazolyl, dibenzofuranyl, dibenzothiophenyl, oxazolyl and oxadiazolyl groups. Further, as the substituent of these aromatic hydrocarbon groups or aromatic heterocyclic groups, halogen atom, hydroxyl group, cyano group, nitro group, amino group, trifluoromethyl group, alkyl group having 1 to 6 carbon atoms, alkoxy group , Aryloxy group, phenyl group, styryl group, naphthyl group, thiophenyl group, aralkyl group, biphenyl group, bithiophenyl group, furanyl group, bifuranyl group, pyronyl group, bipyronyl group and the like.

【0007】前記一般式(1)中のAで表される基の具
体例を表1に示す。
Specific examples of the group represented by A in the general formula (1) are shown in Table 1.

【表1−(1)】 [Table 1- (1)]

【0008】[0008]

【表1−(2)】 [Table 1- (2)]

【0009】また、前記一般式(1)で表されるオキサ
ジアゾール誘導体において、R1〜R2に示される置換基
としては以下のものが挙げられる。 (1)ハロゲン原子、水酸基、トリフルオロメチル基、
シアノ基、ニトロ基。 (2)アルキル基:好ましくはC1〜C6、とりわけC1
〜C4の直鎖または分岐鎖のアルキル基であり、これら
のアルキル基にはフッ素原子、水酸基、シアノ基、アル
コキシ基、フェニル基、またはハロゲン原子、アルキル
基もしくはアルコキシ基置換フェニル基等で置換されて
いてもよい。 (3)アリール基:炭素環式あるいは複素環式芳香環で
あり、フェニル、ナフチル、アントリル、アセナフテニ
ル、フルオレニル、フェナントリル、インデニル、ピレ
ニル、ピリジル、ピリミジル、フラニル、ピロニル、チ
オフェニル、キノリル、ベンゾフラニル、ベンゾチオフ
ェニル、インドリル、カルバゾリル、ベンゾオキサゾリ
ル、キノキサリル、ベンゾイミダゾリル、ピラゾリル、
ジベンゾフラニル、ジベンゾチオフェニル等を示し、こ
れらのアリール基はさらにハロゲン原子、水酸基、シア
ノ基、ニトロ基、アルキル基、アルコキシ基、アミノ基
等で置換されていてもよい。 (4)アルコキシ基(−OR3):R3は(2)で定義し
たアルキル基を表わす。 (5)アリールオキシ基:アリール基として(3)で定
義した基を示す。 (6)アルキルチオ基(−SR3):R3は(2)で定義
した基を示す。 アルキル基、アセチル基、ベンゾイル基等のアシル基、
または、(3)で定義したアリール基を表わし、また、
ピペリジル基、モルホリル基のように、R4とR5とが窒
素原子と共同で環を形成してもよい。また、ユロリジル
基のようにアリール基上の炭素原子と共同で環を形成し
てもよい。 (8)アルコキシカルボニル基(−COOR6):R6
(2)で定義したアルキル基、または、(3)で定義し
たアリール基を示す。 5及びR6は上記で定義した意味を表わす。ただし、R
4およびR5において窒素原子と共同で環を形成する場合
を除く。 (10)メチレンジオキシ基またはメチレンジチオ基等の
アルキレンジオキシ基またはアルキレンジチオ基を示
す。 (11)スチリル基(−CH=CH−C65−R7):式
中、R7は(1)〜(10)で定義した置換基または水素
原子を示す。
The oxa represented by the general formula (1)
In the diazole derivative, R1~ R2Substituent
The following may be mentioned. (1) Halogen atom, hydroxyl group, trifluoromethyl group,
Cyano group, nitro group. (2) Alkyl group: preferably C1~ C6, Especially C1
~ CFourA straight chain or branched chain alkyl group of
The alkyl group of is a fluorine atom, hydroxyl group, cyano group,
Coxy group, phenyl group, or halogen atom, alkyl
Substituted with a phenyl group or a substituted group or an alkoxy group
You may stay. (3) Aryl group: carbocyclic or heterocyclic aromatic ring
Yes, phenyl, naphthyl, anthryl, acenaphthenic
Le, fluorenyl, phenanthryl, indenyl, pyret
Nyl, pyridyl, pyrimidyl, furanyl, pyronyl, thiyl
Ophenyl, quinolyl, benzofuranyl, benzothiof
Phenyl, indolyl, carbazolyl, benzoxazoli
, Quinoxalyl, benzimidazolyl, pyrazolyl,
Dibenzofuranyl, dibenzothiophenyl, etc.
These aryl groups also include halogen atoms, hydroxyl groups, and
Group, nitro group, alkyl group, alkoxy group, amino group
Etc. may be substituted. (4) Alkoxy group (-OR3): R3Is defined in (2)
Represents an alkyl group. (5) Aryloxy group: The aryl group defined in (3)
The defined group is shown. (6) Alkylthio group (-SR3): R3Is defined in (2)
The group represented by Acyl group such as alkyl group, acetyl group, benzoyl group,
Or represents an aryl group defined in (3),
R such as piperidyl group and morpholyl groupFourAnd RFiveToga
It may form a ring together with the elementary atom. Also, Yulorizil
Form a ring in cooperation with carbon atoms on the aryl group, such as
May be. (8) Alkoxycarbonyl group (-COOR6): R6Is
The alkyl group defined in (2) or defined in (3)
Represents an aryl group. RFiveAnd R6Represents the meaning defined above. However, R
FourAnd RFiveForming a ring with a nitrogen atom in
except for. (10) such as methylenedioxy group or methylenedithio group
Indicates an alkylenedioxy group or alkylenedithio group
You (11) Styryl group (-CH = CH-C6HFive-R7):formula
Medium, R7Is a substituent or hydrogen defined in (1) to (10)
Indicates an atom.

【0010】本発明における前記一般式(1)で表され
るオキサジアゾール誘導体は、前記下記一般式(2)で
表される酸ハライド、具体的には下記一般式(10)、
(11)、(12)又は(13)
The oxadiazole derivative represented by the general formula (1) in the present invention is an acid halide represented by the following general formula (2), specifically, the following general formula (10),
(11), (12) or (13)

【化10】 [Chemical 10]

【化11】 [Chemical 11]

【化12】 [Chemical 12]

【化13】 〔式中、(10)、(11)、(12)、(13)中、
2は前記と同じ〕で表される酸ハライド化合物と、下
記一般式(3)
[Chemical 13] [Wherein (10), (11), (12), (13),
R 2 is the same as above] and an acid halide compound represented by the following general formula (3)

【化3】 〔式中、A及びR1は前記と同じ〕で表されるテトラゾ
ール化合物とを反応させることによって製造することが
できる。
[Chemical 3] It can be produced by reacting with a tetrazole compound represented by the formula: wherein A and R 1 are the same as above.

【0011】また、本発明における前記一般式(1)で
表されるオキサジアゾール誘導体は、前記一般式(4)
で表されるテトラゾール化合物、具体的には、下記一般
式(14)、(15)、(16)又は(17)
Further, the oxadiazole derivative represented by the general formula (1) in the present invention has the general formula (4)
A tetrazole compound represented by, specifically, the following general formula (14), (15), (16) or (17)

【化14】 [Chemical 14]

【化15】 [Chemical 15]

【化16】 [Chemical 16]

【化17】 〔式(14)、(15)、(16)、(17)中、R2
は前記と同じ〕で表されるテトラゾール化合物と、下記
一般式(5)
[Chemical 17] [In the formulas (14), (15), (16) and (17), R 2
Is the same as the above] and a tetrazole compound represented by the following general formula (5)

【化5】 〔式中、A、R1及びXは前記と同じ〕で表される酸ハ
ライド化合物とを反応させることによって製造すること
ができる。
[Chemical 5] It can be produced by reacting with an acid halide compound represented by the formula [wherein A, R 1 and X are the same as above].

【0012】また、前記一般式(3)で表されるテトラ
ゾール化合物は、下記一般式(18)
The tetrazole compound represented by the general formula (3) has the following general formula (18)

【化18】 〔式中、A及びR1は前記と同じ〕で表される化合物と
互変異性の関係にあって、互に変化しやすく、別々に取
り出すことが困難なものであり、両者が混在したもので
あるのが一般的である。従って、前記一般式(3)及び
前記一般式(18)のテトラゾール化合物は、それぞれ
が単独であるものの他に両者が混在したものについても
使用できる。また、前記一般式(14)から前記一般式
(17)で表されるテトラゾール化合物についても同様
である。更にまた、前記一般式(3)で表されるテトラ
ゾール化合物は、下記一般式(19)
[Chemical 18] [Wherein A and R 1 are the same as the above] in a tautomeric relationship with each other, which easily change each other and are difficult to take out separately. Is generally. Therefore, the tetrazole compounds of the general formula (3) and the general formula (18) can be used not only individually but also as a mixture of both. The same applies to the tetrazole compounds represented by the general formulas (14) to (17). Furthermore, the tetrazole compound represented by the general formula (3) has the following general formula (19):

【化19】 〔式中、A及びR1は前記と同じ〕で表されるシアノ化
合物を原料として、テトラゾール化することによって製
造することができる。その方法として、例えば、Syn
thesis71(1973)に記載された合成法を適
用することができる。また、前記一般式(14)から一
般式(17)で表されるテトラゾール化合物についても
同様の方法で製造できる。
[Chemical 19] [In the formula, A and R 1 are the same as the above], and can be produced by forming a tetrazole using a cyano compound as a raw material. As the method, for example, Syn
The synthesis method described in thesis 71 (1973) can be applied. Further, the tetrazole compounds represented by the general formulas (14) to (17) can also be produced by the same method.

【0013】これら本発明のオキサジアゾール化合物の
製造方法は、R.D.Huisgenらによるオキサジ
アゾール合成法に準じて行われる。例えば、Ange
w.Chem.,72,366(1960)、Che
m.Ber.,93,2106(1960)、Tetr
ahedron,11,241(1960)、Che
m.Ber.,98,2966(1965)に記載の方
法を適用することができる。
The method for producing these oxadiazole compounds of the present invention is described in R. D. It is performed according to the oxadiazole synthesis method by Huisgen et al. For example, Ange
w. Chem. , 72, 366 (1960), Che
m. Ber. , 93, 2106 (1960), Tetr
ahedron, 11, 241 (1960), Che
m. Ber. , 98, 2966 (1965).

【0014】さらに、別法として、前記一般式(1)で
表されるオキサジアゾール誘導体は、下記一般式(2)
Further, as an alternative method, the oxadiazole derivative represented by the general formula (1) is represented by the following general formula (2).

【化2】 〔式中、R2、X及びnは、前記と同じ。〕で表される
酸ハライド化合物と、下記一般式(20)
[Chemical 2] [In formula, R < 2 >, X and n are the same as the above. ] The acid halide compound represented by the following general formula (20)

【化20】 〔式中、Aは前記と同じ。〕で表される化合物とを反応
させて、次いで得られた生成物に脱水を行うことによっ
ても製造することができる。
[Chemical 20] [In formula, A is the same as the above. ] It can also manufacture by making it react with the compound represented by these, and dehydrating the obtained product next.

【0015】また、他の別法として、前記一般式(1)
で表されるオキサジアゾール誘導体は、下記一般式(2
1)
As another alternative, the above-mentioned general formula (1)
The oxadiazole derivative represented by the following general formula (2
1)

【化21】 〔式中、R1及びnは、前記と同じ。〕で表される化合
物、下記一般式(5)
[Chemical 21] [In formula, R < 1 > and n are the same as the above. ] The compound represented by the following general formula (5)

【化5】 〔式中、A、R2及びXは前記と同じ。〕で表される化
合物とを反応させて、次いで得られた生成物を脱水反応
することによっても製造することができる。
[Chemical 5] [In the formula, A, R 2 and X are the same as defined above. ] It can manufacture also by making it react with the compound represented by these, and then dehydrating the obtained product.

【0016】前記一般式(2)で表される酸ハライド化
合物と前記一般式(20)で表される化合物との反応、
及び上記一般式(21)で表される化合物と前記一般式
(5)で表される化合物との反応は、通常塩基性触媒の
存在下で行なわれる、該塩基性触媒としては、ピリジン
及びその誘導体、トリエチルアミン、トリブチルアミ
ン、トリエタノールアミン、キノリン、ピペラジン、モ
ルホリン等の有機塩基あるいは水酸化ナトリウム、水酸
化カリウム、炭酸ナトリウム等の無機塩基が挙げられる
が、特に有機の塩基性触媒が好ましい。該工程の反応溶
媒としては、原料を溶かすものであればすべてのものが
使用できるが、エタノール、ブタノール等のアルコール
系溶媒、ジオキサン、テトラヒドロフラン等のエーテル
系溶媒、ベンゼン、トルエン、クロルベンゼン、ニトロ
ベンゼン等の芳香族系溶媒、N,N−ジメチルホルムア
ミド、ジメチルスルホキシド等が好ましい。また、前記
ピリジン等の有機の塩基性触媒を過剰に用い、溶媒とし
ても良い。
A reaction between the acid halide compound represented by the general formula (2) and the compound represented by the general formula (20),
And the reaction of the compound represented by the general formula (21) with the compound represented by the general formula (5) is usually carried out in the presence of a basic catalyst. Examples thereof include derivatives, organic bases such as triethylamine, tributylamine, triethanolamine, quinoline, piperazine and morpholine, and inorganic bases such as sodium hydroxide, potassium hydroxide and sodium carbonate, and organic basic catalysts are particularly preferable. As the reaction solvent in this step, any solvent can be used as long as it dissolves the raw materials, but alcohol solvents such as ethanol and butanol, ether solvents such as dioxane and tetrahydrofuran, benzene, toluene, chlorobenzene, nitrobenzene and the like. The aromatic solvents, N, N-dimethylformamide, dimethylsulfoxide and the like are preferable. Further, an organic basic catalyst such as pyridine may be used in excess and used as a solvent.

【0017】また、それによって得られた生成物より脱
水反応によってオキサジアゾール誘導体を合成する反応
は、オキシ塩化リン、塩化チオニル、ポリリン酸、ホウ
酸、トルエン、スルホン酸等の脱水剤の存在下に行う。
この時の反応溶媒としては、前記工程で示した溶媒が使
用できるが、クロルベンゼン、ジクロルベンゼン、キシ
レン、ニトロベンゼン等の芳香族系溶媒、トリクロルメ
タン等のハロゲン系溶媒等が特に好ましい。脱水剤の使
用量は出発原料化合物1モルに対して1モルから10モ
ル程度が適切であるが、例えば、オキシ塩化リンを大過
剰に用い溶媒としても良い。通常、反応は50℃から3
00℃で数分から10時間で完了する。
The reaction for synthesizing the oxadiazole derivative from the product thus obtained by a dehydration reaction is carried out in the presence of a dehydrating agent such as phosphorus oxychloride, thionyl chloride, polyphosphoric acid, boric acid, toluene and sulfonic acid. To do.
As the reaction solvent at this time, the solvent shown in the above step can be used, but aromatic solvents such as chlorobenzene, dichlorobenzene, xylene and nitrobenzene, and halogen solvents such as trichloromethane are particularly preferable. The amount of the dehydrating agent to be used is appropriately about 1 mol to 10 mol with respect to 1 mol of the starting material compound, but, for example, phosphorus oxychloride may be used in a large excess as a solvent. Usually the reaction is from 50 ° C to 3
Completed in minutes to 10 hours at 00 ° C.

【0018】本発明の前記一般式(1)で表されるオキ
サジアゾール誘導体は、有機電界発光素子の構成成分と
して特に優れており、例えば、真空蒸着法、溶液塗布法
等により薄膜化し、陽極及び陰極で直接または間接的に
狭持することによって素子を得ることができる。
The oxadiazole derivative represented by the above general formula (1) of the present invention is particularly excellent as a constituent component of an organic electroluminescent device. For example, it is formed into a thin film by a vacuum deposition method, a solution coating method or the like, And the device can be obtained by sandwiching directly or indirectly with the cathode.

【0019】[0019]

【実施例】以下、本発明を実施例に基づいてさらに詳細
に説明する。なお、本発明はこれらの実施例により限定
されるものではない。
The present invention will be described in more detail based on the following examples. The present invention is not limited to these examples.

【0020】合成例1 下記構造式(22)で表される化合物の合成Synthesis Example 1 Synthesis of compound represented by structural formula (22) below

【化22】 N,N−ジフェニルアミノベンズアルデヒド15.00
g、塩酸ヒドロキシルアミン4.60g、無水酢酸1
1.30g、乾燥DMF40mlを反応容器に入れ、溶
媒としてピリジン6.51gを徐々に加え、138℃に
て2.5時間加熱還流した。放冷後、水500mlに反
応物を注ぎ、水酸化ナトリウム水溶液でアルカリ性にし
た後、沈殿物を濾過し水洗を行った。得られた沈殿物を
トルエンで抽出し水洗及び乾燥を行い、粗収物13.4
9g(収率90.9%)を得た。得られた粗収物をカラ
ムクロマトグラフィー(展開溶媒:トルエン)によって
精製を行い、さらにヘキサンにて再結晶を行うことによ
って12.66g(収率85.2%)の透明針状晶を得
た。融点は、125.8〜126.5℃であり、赤外線
吸収スペクトルによって2200cm-1にかけてC≡N
伸縮振動に帰属されるピークが観察され、目的物である
ことを確認した。
[Chemical formula 22] N, N-diphenylaminobenzaldehyde 15.00
g, hydroxylamine hydrochloride 4.60 g, acetic anhydride 1
1.30 g and 40 ml of dry DMF were placed in a reaction vessel, 6.51 g of pyridine as a solvent was gradually added, and the mixture was heated under reflux at 138 ° C. for 2.5 hours. After allowing to cool, the reaction product was poured into 500 ml of water, made alkaline with an aqueous sodium hydroxide solution, and the precipitate was filtered and washed with water. The obtained precipitate was extracted with toluene, washed with water and dried to obtain a crude product 13.4.
9 g (yield 90.9%) was obtained. The obtained crude product was purified by column chromatography (developing solvent: toluene) and further recrystallized from hexane to obtain 12.66 g (yield 85.2%) of transparent needle crystals. . The melting point is 125.8 to 126.5 ° C. and C≡N over 2200 cm −1 according to the infrared absorption spectrum.
A peak attributed to stretching vibration was observed, and it was confirmed to be the target product.

【0021】合成例2 下記構造式(23)で表される化合物の合成Synthesis Example 2 Synthesis of compound represented by structural formula (23) below

【化23】 合成例1で得られた4−シアノトリフェニルアミン1
1.50gとアジ化ソーダ5.40g、塩化アンモニウ
ム4.44g、さらに溶媒として乾燥DMF50mlを
加え、115〜120℃において75時間加熱還流し
た。放冷後、DMFを除き水500mlに注いで、濃塩
酸により酸性にした。沈殿物を濾過し中性を示すまで水
洗を行い、乾燥して粗収物13.28g(収率99.6
%)を得た。得られた粗収物をトルエンにて再結晶を行
い、12.21g(収率91.5%)の白褐色粉末を得
た。融点は、216.3〜217.3℃であり、赤外線
吸収スペクトルによって2200cm-1のC≡N伸縮振
動に帰属させるピークが消失し、2600〜3100c
-1にかけてのN−H伸縮振動に帰属されるピークが観
察された。さらに、元素分析の結果によって目的物であ
ることを確認した。
[Chemical formula 23] 4-Cyanotriphenylamine 1 obtained in Synthesis Example 1
1.50 g, sodium azide 5.40 g, ammonium chloride 4.44 g, and dry DMF 50 ml as a solvent were added, and the mixture was heated under reflux at 115 to 120 ° C. for 75 hours. After cooling, DMF was removed and the mixture was poured into 500 ml of water and acidified with concentrated hydrochloric acid. The precipitate was filtered, washed with water until it became neutral, and dried to obtain 13.28 g of a crude product (yield 99.6).
%) Was obtained. The obtained crude product was recrystallized from toluene to obtain 12.21 g (yield 91.5%) of white brown powder. The melting point is 216.3 to 217.3 ° C., and the peak attributed to the C≡N stretching vibration at 2200 cm −1 disappears due to the infrared absorption spectrum.
A peak attributed to N—H stretching vibration up to m −1 was observed. Furthermore, it was confirmed by the results of elemental analysis that the product was the target.

【表2】 [Table 2]

【0022】実施例1 下記構造式(24)で表される化合物の合成Example 1 Synthesis of compound represented by structural formula (24) below

【化24】 下記構造式(25)[Chemical formula 24] The following structural formula (25)

【化25】 で表される酸クロライド化合物1.10gと合成例2で
得られたテトラゾール化合物3.14gを反応容器に入
れ、溶媒として乾燥ピリジン90mlを加え、107℃
において58時間加熱環流した。放冷後、水700ml
に注ぎ、沈殿物を濾過し乾燥して粗収物2.71g(収
率77.2%)を得た。得られた粗収物はカラムクロマ
トグラフィー(展開溶媒:クロロホルム/THF=30
/1)によって2回精製を行い、トリエン/エタノール
によって再結晶を行い、さらにメタノール洗浄を行うこ
とによって、1.39g(収率39.6%)の乳白色粉
末を得た。融点は、240.0〜241.0℃であり、
赤外線吸収スペクトルによって、2600〜3100c
-1にかけてのN−H伸縮振動に帰属されるピークが消
失し、C=C伸縮振動に帰属されるピークが観察され、
さらに、元素分析の結果によって目的物であることを確
認した。
[Chemical 25] 1.10 g of the acid chloride compound represented by and 3.14 g of the tetrazole compound obtained in Synthesis Example 2 were placed in a reaction vessel, 90 ml of dry pyridine was added as a solvent, and 107 ° C.
Heated to reflux for 58 hours. After cooling, 700 ml of water
Then, the precipitate was filtered and dried to obtain 2.71 g (yield 77.2%) of a crude product. The crude product thus obtained was subjected to column chromatography (developing solvent: chloroform / THF = 30).
/ 1) twice, recrystallized with triene / ethanol, and washed with methanol to obtain 1.39 g (yield 39.6%) of a milky white powder. The melting point is 240.0-241.0 ° C.,
2600-3100c depending on infrared absorption spectrum
The peak attributed to N—H stretching vibration over m −1 disappeared, and the peak attributable to C═C stretching vibration was observed.
Furthermore, it was confirmed by the results of elemental analysis that the product was the target.

【表3】 [Table 3]

【0023】実施例2 下記構造式(26)で表される化合物の合成Example 2 Synthesis of compound represented by structural formula (26) below

【化26】 下記構造式(27)[Chemical formula 26] The following structural formula (27)

【化27】 で表される酸クロライド化合物1.10gと合成例2で
得られたテトラゾール化合物3.14gを反応容器に入
れ、溶媒として乾燥ピリジン90mlを加え、107℃
において57時間加熱環流した。放冷後、水700ml
に注ぎ、沈殿物を濾過し乾燥して粗収物2.72g(収
率77.5%)を得た。得られた粗収物はカラムクロマ
トグラフィー(展開溶媒:クロロホルム/THF=20
/1)によって精製を行い、トルエン/エタノールによ
って再結晶を行い、1.85g(収率52.7%)の乳
白色粉末を得た。融点は、270.0〜271.0℃で
あり、赤外線吸収スペクトルによって、2600〜31
00cm-1にかけてのN−H伸縮振動に帰属されるピー
クが消失し、C=C伸縮振動に帰属されるピークが観察
され、さらに、元素分析の結果によって目的物であるこ
とを確認した。
[Chemical 27] 1.10 g of the acid chloride compound represented by and 3.14 g of the tetrazole compound obtained in Synthesis Example 2 were placed in a reaction vessel, 90 ml of dry pyridine was added as a solvent, and 107 ° C.
Heated to reflux for 57 hours. After cooling, 700 ml of water
Then, the precipitate was filtered and dried to obtain 2.72 g of a crude product (yield 77.5%). The obtained crude product was subjected to column chromatography (developing solvent: chloroform / THF = 20).
/ 1) and recrystallized from toluene / ethanol to obtain 1.85 g (yield 52.7%) of milky white powder. The melting point is 270.0 to 271.0 ° C., which is 2600 to 31 by infrared absorption spectrum.
The peak attributed to the NH stretching vibration up to 00 cm -1 disappeared, the peak attributed to the C = C stretching vibration was observed, and the result of elemental analysis confirmed that it was the desired product.

【表4】 [Table 4]

【0024】実施例3 下記構造式(28)で表される化合物の合成Example 3 Synthesis of compound represented by structural formula (28) below

【化28】 下記構造式(29)[Chemical 28] The following structural formula (29)

【化29】 で表される酸クロライド化合物1.02gと合成例2で
得られたテトラゾール化合物3.14gを反応容器に入
れ、溶媒として乾燥ピリジン90mlを加え、106℃
において51時間加熱環流した。放冷後、水600ml
に注ぎ、沈殿物を濾過し、乾燥して粗収物2.11g
(収率60.1%)を得た。得られた粗収物はカラムク
ロマトグラフィー(展開溶媒:クロロホルム/THF=
30/1)によって精製を行った後、再度カラムクロマ
トグラフィー(展開溶媒:トルエン/酢酸エチル=5/
1)によって2回精製を行った。得られた精製品は、メ
タノール洗浄を行い、トルエン/ヘキサンによって再結
晶を行い、0.70g(収率20.0%)の淡緑色粉末
を得た。融点は、217.0〜218.0℃であり、赤
外線吸収スペクトルによって、2600〜3100cm
-1にかけてのN−H伸縮振動に帰属されるピークが消失
し、C=C伸縮振動に帰属されるピークが観察され、さ
らに、元素分析の結果によって目的物であることを確認
した。
[Chemical 29] 1.02 g of the acid chloride compound represented by and the tetrazole compound 3.14 g obtained in Synthesis Example 2 were placed in a reaction vessel, 90 ml of dry pyridine was added as a solvent, and 106 ° C.
Heated at reflux for 51 hours. After cooling, 600 ml of water
And the precipitate is filtered and dried to give 2.11 g of crude product.
(Yield 60.1%) was obtained. The obtained crude product was subjected to column chromatography (developing solvent: chloroform / THF =
30/1) and then column chromatography (developing solvent: toluene / ethyl acetate = 5 /) again.
Purification was performed twice according to 1). The obtained purified product was washed with methanol and recrystallized with toluene / hexane to obtain 0.70 g (yield 20.0%) of a pale green powder. The melting point is 217.0 to 218.0 ° C., which is 2600 to 3100 cm according to the infrared absorption spectrum.
The peak attributed to N—H stretching vibration over −1 disappeared, and the peak attributed to C═C stretching vibration was observed. Furthermore, it was confirmed by the result of elemental analysis that the product was the target.

【表5】 [Table 5]

【0025】実施例4 下記構造式(30)で表される化合物の合成Example 4 Synthesis of compound represented by structural formula (30) below

【化30】 下記構造式(31)[Chemical 30] The following structural formula (31)

【化31】 で表される酸クロライド化合物0.76gと合成例2で
得られたテトラゾール化合物2.69gを反応容器に入
れ、溶媒として乾燥ピリジン35mlを加え、102℃
において72時間加熱環流した。放冷後、水600ml
に注ぎ、沈殿物を濾過し、乾燥して粗収物2.53g
(収率87.2%)を得た。得られた粗収物はカラムク
ロマトグラフィー(展開溶媒:クロロホルム/THF=
30/1)によって精製を行った後、メタノール洗浄を
行い、再度カラムクロマトグラフィー(展開溶媒:クロ
ロホルム/THF=30/1)によって精製を行った。
得られた精製品は、トルエン/メタノールによって2回
再結晶を行い、0.81g(収率27.9%)の淡緑色
粉末を得た。融点は、237.0〜238.0℃であ
り、赤外線吸収スペクトルによって、2600〜310
0cm-1にかけてのN−H伸縮振動に帰属されるピーク
が消失し、C=C伸縮振動に帰属されるピークが観察さ
れ、さらに、元素分析の結果によって目的物であること
を確認した。
[Chemical 31] Into a reaction vessel, 0.76 g of the acid chloride compound represented by the formula and 2.69 g of the tetrazole compound obtained in Synthesis Example 2 were added, and 35 ml of dry pyridine was added as a solvent.
Heated to reflux for 72 hours. After cooling, 600 ml of water
2.53g of crude product
(Yield 87.2%) was obtained. The obtained crude product was subjected to column chromatography (developing solvent: chloroform / THF =
After purification by 30/1), washing with methanol was performed, and purification was performed again by column chromatography (developing solvent: chloroform / THF = 30/1).
The obtained purified product was recrystallized twice with toluene / methanol to obtain 0.81 g (yield 27.9%) of a pale green powder. The melting point is 237.0 to 238.0 ° C., and it is 2600 to 310 according to the infrared absorption spectrum.
The peak attributed to the NH stretching vibration at 0 cm -1 disappeared, the peak attributed to the C = C stretching vibration was observed, and the result of elemental analysis confirmed that it was the desired product.

【表6】 [Table 6]

【0026】[0026]

【応用例】[Application example]

応用例1 陽極として大きさ2mm×2mm、厚さ170mmの酸
化錫インジウム(ITO)が形成されたガラス基板上
に、下記構造式(32)で示される化合物からなるホー
ル輪送層40nm、前記構造式(26)で示されるオキ
サジアゾール誘導体からなる発光層35nm、下記構造
式(33)で示される8−ヒドロキシキノリン錯体から
なる電子輸送層25nm、さらに10:1原子比のMg
Ag電極を200nmを順次真空蒸着により積層して電
界発光素子を作製した。蒸着時の真空度は約1×10-4
Paであり、基板温度は室温である。なお、ITO基板
には蒸着前にプラズマ処理を施した。このようにして作
製した素子の陽極及び陰極にリード線を介して直流電源
を接続し素子を駆動させたところ、電流密度30mA/
cm2において、印加電圧が5.6V、輝度が1450
cd/m2(発光効率:2.71lm/W)発光波長が
490nmの緑色の発光が観察され、発光の高輝度化が
実現された。なお、この素子は3ヶ月保存後においても
明瞭に発光が確認された。
Application Example 1 On a glass substrate on which indium tin oxide (ITO) having a size of 2 mm × 2 mm and a thickness of 170 mm is formed as an anode, a hole transport layer 40 nm composed of a compound represented by the following structural formula (32), the above structure A light emitting layer 35 nm composed of an oxadiazole derivative represented by the formula (26), an electron transporting layer 25 nm composed of an 8-hydroxyquinoline complex represented by the following structural formula (33), and further 10: 1 atomic ratio of Mg.
An electroluminescent device was produced by sequentially stacking 200 nm of Ag electrodes by vacuum vapor deposition. The degree of vacuum during vapor deposition is approximately 1 × 10 -4
Pa and the substrate temperature is room temperature. The ITO substrate was plasma-treated before vapor deposition. When a direct current power supply was connected to the anode and the cathode of the element thus manufactured through a lead wire to drive the element, the current density was 30 mA /
In cm 2 , the applied voltage is 5.6 V and the brightness is 1450
cd / m 2 (luminous efficiency: 2.71 lm / W) Green light emission with a light emission wavelength of 490 nm was observed, and high luminance of light emission was realized. In addition, it was confirmed that the device emitted light clearly even after storage for 3 months.

【化32】 [Chemical 32]

【化33】 [Chemical 33]

【0027】応用例2 発光材料として、前記構造式(26)で示されるオキサ
ジアゾール誘導体の代わりに前記構造式(24)で示さ
れるオキサジアゾール誘導体を用いた以外は、応用例1
と同様にして電界発光素子を作製した。このようにして
作製した素子の陽極及び陰極にリード線を介して直流電
源を接続し素子を駆動させたところ、電流密度30mA
/cmにおいて、印加電圧が7.0V、輝度が620
cd/m(発光効率:0.93lm/W)、発光波長
が460nmの色の発光が観察され、発光の高輝度化
が実現された。なお、この素子は3ヶ月保存後において
も明瞭に発光が確認された。
Application Example 2 Application Example 1 except that the oxadiazole derivative represented by the structural formula (24) is used as a light emitting material instead of the oxadiazole derivative represented by the structural formula (26).
An electroluminescent device was produced in the same manner as in. When a direct current power supply was connected to the anode and the cathode of the element thus manufactured through a lead wire to drive the element, the current density was 30 mA.
/ Cm 2 , applied voltage is 7.0 V, brightness is 620
cd / m 2 (luminous efficiency: 0.93lm / W), the emission wavelength was observed the emission of 460nm blue color, high brightness light was achieved. In addition, it was confirmed that the device emitted light clearly even after storage for 3 months.

【0028】応用例3 陽極として大きさ2mm×2mm、厚さ170mmの酸
化錫インジウム(ITO)が形成されたガラス基板上
に、前記構造式(32)で示される化合物からなるホー
ル輪送層40nm、前記構造式(26)で示されるオキ
サジアゾール誘導体からなる発光層15nm、下記構造
式(34)で示されるオキサジアゾール化合物からなる
電子輸送層20nm、上記構造式(33)で示される8
−ヒドロキシキノリン錯体からなる電子注入層25n
m、さらに10:1原子比のMgAg電極を200nm
を順次真空蒸着により積層して電界発光素子を作製し
た。蒸着時の真空度は約1×10-4Paであり、基板温
度は室温である。なお、ITO基板には蒸着前にプラズ
マ処理を施した。このようにして作製した素子の陽極及
び陰極にリード線を介して直流電源を接続し素子を駆動
させたところ、電流密度30mA/cm2において、印
加電圧が9.1V、輝度が1800cd/m2(発光効
率:2.07lm/W)、発光波長が490nmの緑色
の発光が観察され、発光の高輝度化が実現された。な
お、この素子は3ヶ月保存後においても明瞭に発光が確
認された。
Application Example 3 On a glass substrate on which indium tin oxide (ITO) having a size of 2 mm × 2 mm and a thickness of 170 mm was formed as an anode, a hole transport layer 40 nm composed of the compound represented by the structural formula (32) was used. A light emitting layer 15 nm composed of the oxadiazole derivative represented by the structural formula (26), an electron transport layer 20 nm composed of the oxadiazole compound represented by the following structural formula (34), and 8 represented by the structural formula (33).
-Electron injection layer 25n made of hydroxyquinoline complex
m, and a MgAg electrode with a 10: 1 atomic ratio of 200 nm
Were sequentially laminated by vacuum vapor deposition to fabricate an electroluminescent device. The degree of vacuum during vapor deposition is about 1 × 10 −4 Pa, and the substrate temperature is room temperature. The ITO substrate was plasma-treated before vapor deposition. When a direct current power supply was connected to the anode and cathode of the device thus manufactured through a lead wire to drive the device, the applied voltage was 9.1 V and the brightness was 1800 cd / m 2 at a current density of 30 mA / cm 2 . (Emission efficiency: 2.07 lm / W), green emission with an emission wavelength of 490 nm was observed, and higher luminance of emission was realized. In addition, it was confirmed that the device emitted light clearly even after storage for 3 months.

【化34】 [Chemical 34]

【0029】応用例4 ホール輸送材料として前記構造式(32)で示される化
合物の代わりに下記構造式(35)で示される化合物
を、また、発光材料として、前記構造式(26)で示さ
れるオキサジアゾール誘導体の代わりに前記構造式(2
8)で示されるオキサジアゾール誘導体を用いた以外
は、応用例3と同様にして電界発光素子を作製した。こ
のようにして作製した素子の陽極及び陰極にリード線を
介して直流電源を接続し素子を駆動させたところ、電流
密度30mA/cm2において、印加電圧が12.0
V、輝度が720cd/m2(発光効率:0.63lm
/W)、発光波長が470nmの青色の発光が観察さ
れ、発光の高輝度化が実現された。なお、この素子は3
ヶ月保存後においても明瞭に発光が確認された。
Application Example 4 Instead of the compound represented by the structural formula (32) as the hole transport material, the compound represented by the following structural formula (35) is used, and as the light emitting material, the compound represented by the structural formula (26) is represented. Instead of the oxadiazole derivative, the above structural formula (2
An electroluminescent device was produced in the same manner as in Application Example 3, except that the oxadiazole derivative represented by 8) was used. When a direct current power supply was connected to the anode and cathode of the element thus produced through a lead wire to drive the element, the applied voltage was 12.0 at a current density of 30 mA / cm 2 .
V, brightness 720 cd / m 2 (luminous efficiency: 0.63 lm
/ W), blue light emission with an emission wavelength of 470 nm was observed, and higher luminance of light emission was realized. This element is 3
Even after storage for a month, luminescence was clearly confirmed.

【化35】 [Chemical 35]

【0030】応用例5 発光材料として、上記構造式(28)で示されるオキサ
ジアゾール誘導体の代わりに前記構造式(30)で示さ
れるオキサジアゾール誘導体を用いた以外は、応用例4
と同様にして電界発光素子を作製した。このようにして
作製した素子の陽極及び陰極にリード線を介して直流電
源を接続し素子を駆動させたところ、電流密度30mA
/cm2において、印加電圧が13.5V、輝度が45
3cd/m2(発光効率:0.35lm/W)、発光波
長が500nmの緑色の発光が観察され、発光の高輝度
化が実現された。なお、この素子は3ヶ月保存後におい
ても明瞭に発光が確認された。
Application Example 5 Application Example 4 except that the oxadiazole derivative represented by the above structural formula (30) is used as the light emitting material instead of the oxadiazole derivative represented by the above structural formula (28).
An electroluminescent device was produced in the same manner as in. When a direct current power supply was connected to the anode and the cathode of the element thus manufactured through a lead wire to drive the element, the current density was 30 mA.
/ Cm 2 , the applied voltage is 13.5 V and the brightness is 45
3 cd / m 2 (emission efficiency: 0.35 lm / W), green emission having an emission wavelength of 500 nm was observed, and high luminance of emission was realized. In addition, it was confirmed that the device emitted light clearly even after storage for 3 months.

【0031】比較例1 陽極として大きさ2mm×2mm、厚さ170mmのイ
ンジウム−スズ酸化物(ITO)が形成されたガラス基
板上に、下記構造式(36)で示される化合物からなる
ホール輪送層40nm、下記構造式(37)で示される
アミノピレン誘導体からなる発光層15nm、下記構造
式(38)で示されるオキサジアゾール化合物からなる
電子輸送層20nm、前記構造式(33)で示される8
−ヒドロキシキノリン錯体からなる電子注入層25n
m、さらに10:1原子比のMgAg電極を200nm
を順次真空蒸着により積層して電界発光素子を作製し
た。蒸着時の真空度は約1×10-4Paであり、基板温
度は室温である。このようにして作製した素子の陽極及
び陰極にリード線を介して直流電源を接続し素子を駆動
させたところ、電流密度30mA/cm2において、印
加電圧が5.8V、輝度が325cd/m2、発光波長
が500nmの緑色の発光が観察された。
Comparative Example 1 On a glass substrate on which indium-tin oxide (ITO) having a size of 2 mm × 2 mm and a thickness of 170 mm was formed as an anode, a hole transfer consisting of a compound represented by the following structural formula (36) was carried out. Layer 40 nm, light emitting layer 15 nm composed of aminopyrene derivative represented by the following structural formula (37), electron transport layer 20 nm composed of oxadiazole compound represented by the following structural formula (38), and 8 represented by the structural formula (33).
-Electron injection layer 25n made of hydroxyquinoline complex
m, and a MgAg electrode with a 10: 1 atomic ratio of 200 nm
Were sequentially laminated by vacuum vapor deposition to fabricate an electroluminescent device. The degree of vacuum during vapor deposition is about 1 × 10 −4 Pa, and the substrate temperature is room temperature. When a direct current power supply was connected to the anode and cathode of the device thus produced through a lead wire to drive the device, the applied voltage was 5.8 V and the brightness was 325 cd / m 2 at a current density of 30 mA / cm 2 . A green emission with an emission wavelength of 500 nm was observed.

【化36】 [Chemical 36]

【化37】 [Chemical 37]

【化38】 [Chemical 38]

【0032】比較例2 陽極として、インジウム−スズ酸化物(ITO)が形成
されたガラス基板上に、前記構造式(32)で示される
化合物からなるホール輪送層60nm、下記構造式(3
9)で示されるオキサジアゾール化合物からなる発光層
10nm、下記構造式(40)で示されるオキサジアゾ
ール化合物からなる電子輸送層30nm、さらに10:
1原子比のMgAg電極を200nmを順次真空蒸着に
より積層して電界発光素子を作製した。蒸着時の真空度
は約1×10-4Paであり、基板温度は室温である。こ
のようにして作製した素子の陽極及び陰極にリード線を
介して直流電源を接続し素子を駆動させたところ、電流
密度300mA/cm2において、印加電圧が17V、
輝度が4000cd/m2、(発光効率:0.25lm
/W)、発光波長が521nmの緑色の発光が観察され
た。
Comparative Example 2 As a positive electrode, on a glass substrate on which indium-tin oxide (ITO) was formed, a hole transport layer of 60 nm composed of the compound represented by the structural formula (32), the following structural formula (3)
9) Emissive layer made of oxadiazole compound represented by 10 nm, electron transport layer made of oxadiazole compound represented by the following structural formula (40) 30 nm, further 10:
An electroluminescent device was prepared by sequentially laminating 200 nm of MgAg electrodes having a one-atom ratio by vacuum evaporation. The degree of vacuum during vapor deposition is about 1 × 10 −4 Pa, and the substrate temperature is room temperature. When a direct current power supply was connected to the anode and the cathode of the device thus manufactured through a lead wire to drive the device, the applied voltage was 17 V at a current density of 300 mA / cm 2 .
Luminance is 4000 cd / m 2 , (luminous efficiency: 0.25 lm
/ W), green light emission with an emission wavelength of 521 nm was observed.

【化39】 [Chemical Formula 39]

【化40】 [Chemical 40]

【0033】[0033]

【発明の効果】本発明のオキサジアゾール誘導体は、新
規化合物であって、電子輸送機能を有するオキサジアゾ
ール環と、電子供与機能を有するアリールアミン構造と
を合せ持つバイポーラ性化合物であって、蛍光強度が高
く、特に有機EL素子の発光成分として優れた特性を有
し、このように本発明のオキサジアゾール誘導体を発光
層の発光成分として用い、電荷輸送層の電荷輸送成分と
して従来既知の材料を用いた電界発光素子は、極めて優
れた発光輝度及び発光効率を有する。
The oxadiazole derivative of the present invention is a novel compound, which is a bipolar compound having both an oxadiazole ring having an electron transport function and an arylamine structure having an electron donating function, It has a high fluorescence intensity and particularly has excellent properties as a light emitting component of an organic EL device. Thus, using the oxadiazole derivative of the present invention as a light emitting component of a light emitting layer, it has been conventionally known as a charge transporting component of a charge transporting layer. An electroluminescent device using a material has extremely excellent emission brightness and emission efficiency.

───────────────────────────────────────────────────── フロントページの続き (56)参考文献 特開 平4−363891(JP,A) 特開 平6−65569(JP,A) 特開 平4−115487(JP,A) 特開 平7−109451(JP,A) (58)調査した分野(Int.Cl.7,DB名) C07D 271/10 C07D 413/12,473/14 C09K 11/06 H05B 33/14,33/22 REGISTRY(STN) CA(STN) CAOLD(STN)─────────────────────────────────────────────────── --- Continuation of the front page (56) Reference JP-A-4-363891 (JP, A) JP-A-6-65569 (JP, A) JP-A-4-115487 (JP, A) JP-A-7- 109451 (JP, A) (58) Fields investigated (Int.Cl. 7 , DB name) C07D 271/10 C07D 413 / 12,473 / 14 C09K 11/06 H05B 33 / 14,33 / 22 REGISTRY (STN) CA ( STN) CAOLD (STN)

Claims (2)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 下記一般式(1) 【化1】 〔式中、 Aは、置換もしくは無置換の芳香族炭化水素基、置換も
しくは無置換の芳香族複素環基を表し、それぞれ同一で
も異なっていても良い。R1、R2は、水素原子、ハロゲ
ン原子、置換もしくは無置換のアルキル基、アルコキシ
基、アリール基、アミノ基、シアノ基、ヒドロキシル基
を表し、それぞれ同一でも異なっていても良い。nは、
2又は3の整数を表す(但し、3の場合は、ベンゼン環
の1、3、5位に結合する)。〕で表されるオキサジア
ゾール誘導体。
1. The following general formula (1): [In the formula, A represents a substituted or unsubstituted aromatic hydrocarbon group or a substituted or unsubstituted aromatic heterocyclic group, which may be the same or different. R 1 and R 2 represent a hydrogen atom, a halogen atom, a substituted or unsubstituted alkyl group, an alkoxy group, an aryl group, an amino group, a cyano group and a hydroxyl group, and may be the same or different. n is
It represents an integer of 2 or 3 (however, in the case of 3, it is bonded to the 1, 3 and 5 positions of the benzene ring). ] The oxadiazole derivative represented by these.
【請求項2】 下記一般式(2) 【化2】 〔式中、 R2は、水素原子、ハロゲン原子、置換もしくは無置換
のアルキル基、アルコキシ基、アリール基、アミノ基、
シアノ基、ヒドロキシル基を表す。Xは、ハロゲン原子
を表す。nは、2又は3の整数を表す(但し、3の場合
は、ベンゼン環の1、3、5位に結合する)。〕で表さ
れる酸ハライド化合物と、下記一般式(3) 【化3】 〔式中、 Aは、置換もしくは無置換の芳香族炭化水素基、置換も
しくは無置換の芳香族複素環基を表し、それぞれ同一で
も異なっていても良い。R1は、水素原子、ハロゲン原
子、置換もしくは無置換のアルキル基、アルコキシ基、
アリール基、アミノ基、シアノ基、ヒドロキシル基を表
す。〕で表されるテトラゾール化合物とを反応させて、
請求項1に記載の一般式(1)で表されるオキサジアゾ
ール誘導体を製造することを特徴とするオキサジアゾー
ル誘導体の製造方法。
2. The following general formula (2): [In the formula, R 2 represents a hydrogen atom, a halogen atom, a substituted or unsubstituted alkyl group, an alkoxy group, an aryl group, an amino group,
Represents a cyano group and a hydroxyl group. X represents a halogen atom. n represents an integer of 2 or 3 (however, in the case of 3, it is bonded to the 1, 3, and 5 positions of the benzene ring). ] And an acid halide compound represented by the following general formula (3): [In the formula, A represents a substituted or unsubstituted aromatic hydrocarbon group or a substituted or unsubstituted aromatic heterocyclic group, which may be the same or different. R 1 is a hydrogen atom, a halogen atom, a substituted or unsubstituted alkyl group, an alkoxy group,
It represents an aryl group, an amino group, a cyano group or a hydroxyl group. ] By reacting with a tetrazole compound represented by
A method for producing an oxadiazole derivative, which comprises producing the oxadiazole derivative represented by the general formula (1) according to claim 1 .
JP14675695A 1995-05-22 1995-05-22 Oxadiazole derivative and method for producing the same Expired - Fee Related JP3520880B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP14675695A JP3520880B2 (en) 1995-05-22 1995-05-22 Oxadiazole derivative and method for producing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14675695A JP3520880B2 (en) 1995-05-22 1995-05-22 Oxadiazole derivative and method for producing the same

Publications (2)

Publication Number Publication Date
JPH08311051A JPH08311051A (en) 1996-11-26
JP3520880B2 true JP3520880B2 (en) 2004-04-19

Family

ID=15414870

Family Applications (1)

Application Number Title Priority Date Filing Date
JP14675695A Expired - Fee Related JP3520880B2 (en) 1995-05-22 1995-05-22 Oxadiazole derivative and method for producing the same

Country Status (1)

Country Link
JP (1) JP3520880B2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999052992A1 (en) 1998-04-09 1999-10-21 Idemitsu Kosan Co., Ltd. Organic electroluminescent device
EP1976838B1 (en) * 2005-12-28 2015-02-25 Semiconductor Energy Laboratory Co., Ltd. Oxadiazole derivative, and light emitting element, light emitting device, and electronic device using the oxadiazole derivative
US9112170B2 (en) 2006-03-21 2015-08-18 Semiconductor Energy Laboratory Co., Ltd. Light-emitting element, light-emitting device, and electronic device
TWI480277B (en) 2009-03-20 2015-04-11 Semiconductor Energy Lab Carbazole derivative with heteroaromatic ring, and light-emitting element, light-emitting device, and electronic device using carbazole derivative with heteroaromatic ring
CN114057663B (en) * 2021-10-18 2023-09-08 吉林大学 Triphenylamine derivative with mechanochromatic characteristic and preparation method and application thereof

Also Published As

Publication number Publication date
JPH08311051A (en) 1996-11-26

Similar Documents

Publication Publication Date Title
JP3341090B2 (en) Oxadiazole derivative and method for producing the same
JP5373787B2 (en) Organic electroluminescence device
KR101650595B1 (en) Compound having substituted anthracene ring structure and pyridoindole ring structure and organic electroluminescence device
JP3496080B2 (en) Oxadiazole derivative and method for producing the same
JP5175099B2 (en) Compound having triazole ring structure substituted with pyridyl group and organic electroluminescence device
JP5291463B2 (en) Compound having pyridoindole ring structure in which substituted pyridyl group is linked and organic electroluminescence device
KR20220127220A (en) Organic light-emitting compound and organic electroluminescent device using the same
KR101747976B1 (en) Compound having benzotriazole ring structure and organic electroluminescent element
KR20100106014A (en) Novel organic electroluminescent compounds and organic electroluminescent device using the same
JP2013526014A (en) Novel organic electroluminescent compound and organic electroluminescent device using the same
JPH07228579A (en) Oxadiazole compound and its production
JPH07179394A (en) Oxadiazole compound and its production
KR20120083243A (en) New compounds and organic electronic device using the same
KR20090035974A (en) Cyclopentaphenanthrene-based compound and organic light emitting device employing the same
KR20140125061A (en) An organoelectro luminescent compound and an organoelectroluminescent device using the same
KR20190079181A (en) Organic compounds and organic electro luminescence device comprising the same
KR20180092035A (en) Organic compound and organic electroluminescent device using the same
KR20180024891A (en) Organic compounds and organic electro luminescence device comprising the same
JP2009051764A (en) Substituted phenanthrene ring structure-having compound and organic electroluminescence element
JP3520880B2 (en) Oxadiazole derivative and method for producing the same
JP3518816B2 (en) Oxadiazole compound and method for producing the same
KR101774374B1 (en) Organic electroluminescent compound, producing method of the same and organic electroluminescent divice including the same
JP3537869B2 (en) Oxadiazole compound and method for producing the same
JP3525227B2 (en) Oxadiazole compound and method for producing the same
JP3496081B2 (en) Oxadiazole compound and method for producing the same

Legal Events

Date Code Title Description
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20040107

RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7421

Effective date: 20040122

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20040127

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080213

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090213

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100213

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110213

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120213

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130213

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130213

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140213

Year of fee payment: 10

LAPS Cancellation because of no payment of annual fees